Aclaris Therapeutics (ACRS) Debt Ratio (2017 - 2022)

Aclaris Therapeutics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.01 for Q3 2022.

• On a quarterly basis, Debt Ratio fell 13.55% year-over-year to 0.01 in Q3 2022; TTM through Sep 2022 was 0.01, a 13.55% decrease from a year earlier, with the FY2021 full-year figure at 0.01, down 92.99% from the prior year.
• Debt Ratio advanced to 0.01 in Q3 2022 per ACRS's latest filing, from 0.01 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.19 in Q3 2019 and bottomed at 0.01 in Q2 2022.
• The 5-year median for Debt Ratio is 0.11 (2018), against an average of 0.08.
• Across the five-year window, Debt Ratio jumped 4380.35% in 2018 and plunged 92.99% in 2021, its largest moves.
• Year by year, Debt Ratio stood at 0.11 in 2018, then surged by 71.87% to 0.19 in 2019, then slipped by 19.34% to 0.15 in 2020, then slumped by 92.99% to 0.01 in 2021, then slipped by 4.36% to 0.01 in 2022.
• Per Business Quant, the three latest ACRS Debt Ratio figures stand at 0.01 (Q3 2022), 0.01 (Q2 2022), and 0.01 (Q1 2022).